Institut Produits Synthése (IPSEN) AB
556701-3106ActiveGlobal mid-size pharmaceutical company focused on transformative medicines.
Overview
- 50–99
- Employees
- 500–1000M SEK
- Revenue
- 2006
- Founded
Key Decision Makers
Sally Bain
Head of Global Media Relations
Henry Wheeler
Vice President, Investor Relations
Caroline Sitbon
Executive Vice President, General Counsel
Pierrick Lefranc
Executive Vice President Technical Operations
+39 more contacts in Funnelfeedr
Description
Ipsen is a global, mid-size pharmaceutical company dedicated to addressing areas of high unmet medical need worldwide. The organization employs over 5,000 talented and dedicated professionals globally, striving to discover, innovate, and bring transformative medicines to market. Their core therapeut...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Partihandel med medicinsk utrustning och apoteksvaror
- Legal Form
- Aktiebolag
- VAT Number
- SE556701310601
Decision Makers
43 contacts in FunnelfeedrSally Bain
Head of Global Media Relations
Henry Wheeler
Vice President, Investor Relations
Caroline Sitbon
Executive Vice President, General Counsel
Pierrick Lefranc
Executive Vice President Technical Operations
Christelle Huguet
Executive Vice President, Head of R&D
Madee Gooriah
Senior Director of Global Partnering for Oncology
Florence Meyer-Losic
Vice President and Head of Translational Sciences
Michèle Ollier
Director
Keira Driansky
Executive Vice President, President of North America
Pascal Touchon
Director
Margaret Liu
Director
Carol Xueref
Director
Josep Catllà
Executive Vice President, Chief Corporate Affairs Officer
Régis Mulot
Executive Vice President, Chief Human Resources Officer
Mari Scheiffele
Executive Vice President, Chief Product Officer and head of GPPS
David Loew
Chief Executive Officer
Laetitia Ducroquet
Director
Naomi Binoche
VP Head of Strategic Alliance Management
Philippe Bonhomme
Director
Peter Guenter
Director
Aidan Murphy
Executive Vice President, Head of Technical Operations
Antoine Flochel
Director
Will Olughu
Lead of Chemistry, Manufacturing, and Controls (CMC)
Elisabetta Leo
Head of Early Development
David Jenkins
Senior Vice President, Head of Research & External Innovation
Olivia Brown
Executive Vice President, Global Head of Neurotoxins
Piet Wigerinck
Director
Karen Witts
Director
Laura Réveillon
Executive Vice President, Strategy & Transformation
Eli Leo
Early Development Asset Lead
Anu Connor
Vice President and Head of Oncology External Innovation
Andreas Gerber
Executive Vice President, Head of International
Philippe Lopes-Fernandes
Executive Vice President, Chief Business Officer
Anne Beaufour
Director
Mary Jane Hinrichs
Senior Vice President, and Global Head of Early Development
Marc de Garidel
Chairperson of the Board of Directors
Florence Dal Degan
Senior Director of External Innovation
Sandra Silvestri, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Aymeric Le Chatelier
Executive Vice President, Chief Financial Officer
Anne Liontas
France Media Relations
Khalid Deojee
Senior Manager, Investor Relations
Janaine Oliveira Ferreira
Senior Product Manager
Other Contacts
Lineu Domit
Safety Physician
Similar Companies
20 similar companies in FunnelfeedrAstraZeneca AB
5,000–9,999 employeesGlobal biopharmaceutical company developing life-changing medicines across key areas.
NOVARTIS SVERIGE AKTIEBOLAG
100–199 employeesGlobal innovative medicines company improving and extending people’s lives.
A. Menarini Diagnostics S.r.l., Italien Filial (Sverige)
Italian pharmaceutical group focused on global patient care and innovation.
ASTRAZENECA PLC
1–4 employeesGlobal science-led pharmaceutical business developing life-changing medicines.
ASTRAZENECA AS
102 employeesGlobal science-led pharmaceutical company delivering life-changing medicines across key areas.
Browse More
Institut Produits Synthése (IPSEN) AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo